Whole genome coverage
Standard panel testing looks at less than 0.1% of your genome1. Our whole genome sequencing platforms provide an extensive analysis of your patient’s genomic makeup, including complex mutations (structural variants, copy number variants, variants in non-coding areas) that are not covered by other panel and exome sequencing tests.
Targeted panel sequencing
< 0.1 %
Genome-wide coverage
- Limited number of point mutations
- Limited copy number variations
- Limited structural variations
Whole exome sequencing
1 – 2 %
Genome-wide coverage
- Limited number of point mutations
- Limited copy number variations
- Limited structural variations
- Non-coding areas not covered
Whole genome sequencing
> 99 %
Genome-wide coverage
- More point mutations identified
- More accurate, genome-wide copy number variations
- Genome-wide coverage of structural variations
- Non-coding areas also covered
At Inocras, our goal is to help relieve your diagnostic burden so you can spend more time on what matters most: caring for your patients. Our whole genome platform provides you with additional data, tools, and confidence to support your best medical decision making.
Actionable findings
Our proprietary high-performing bioinformatics algorithm thoroughly analyzes a patient’s genome data and translates it into actionable findings. Our user-friendly report is comprehensive and highlights the findings highly relevant to clinical utility.
Clinical trial matching
We provide detailed clinical trial information matched with each patient’s biomarkers and other pre-screening criteria, saving you time in finding the best matched clinical trials for patients.
*For cancer only
Expert support
You’ll have access to our in-house genomic experts (on demand) while our dedicated sales and medical teams are just a phone call away. Your patient will also have access to a genetic counselor session. This counselor is also available to address any questions you may have.
Available tests
We offer WGS-based diagnostic solutions for cancer and rare diseases.
Cancer
See your patient’s cancer from new angles. Our whole genome cancer test provides a broader insight compared to many conventional genetic tests.
Rare disease
Find clarity in the face of complexity. We combine bioinformatics with in-house clinical expertise to provide timely, accurate, and clinically meaningful insights.
How to order a test
Ordering a test is quick and easy at our provider order portal
01.
Start an online order by filling out the test requisition form. We will send our kits to your office.
02.
Use our supplied sample collection kit and instructions to collect samples for testing.
03.
Ship the samples directly to us.
04.
Receive the test results via email and fax. You can also access all test results you ordered in our online portal.
Test requirements
CancerVision
Specimen
10 FFPE from curls or slides, with an H&E stained slide for reference
Paired normal
10mL peripheral blood, or
previously extracted DNA from a CLIA certified laboratory
Turnaround time
2 weeks from receipt of patient samples at our lab
RareVision
Specimen
Peripheral blood (3-5 mL)
One buccal swab in fixative solution
Turnaround time
2 weeks from receipt of patient samples at our lab
*This testimonial is based on collaborative research funded by Inocras.
Frequently asked questions
If you don’t see your question answered here, please contact us at inquiry@inocras.com.
How do I order a test?
To order a test, please sign up and complete the online test requisition form. Our sales representatives will follow up with you shortly.
How are the tests paid for?
Our tests are not currently covered by insurance. Upon ordering, your patient will receive an invoice for which payment will be required directly from the patient’s out-of-pocket expenses.
How will I receive the results?
You can access Inocras test reports as soon as they are ready via our digital provider order portal. You can also receive access to results via secure email or request to have results faxed to you.
What if I have questions about my patient’s results?
You’ll have access to our team of in-house medical experts, researchers, and genomic scientists who can explain the results to you and answer any questions. If you have questions about a patient’s results, you can email us at inquiry@inocras.com for support. One of our experts will respond to your questions or set up time to speak with you.